Viewing Study NCT01653067


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-02-25 @ 5:43 PM
Study NCT ID: NCT01653067
Status: UNKNOWN
Last Update Posted: 2016-10-27
First Post: 2012-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma
Sponsor: Mathias Witzens-Harig
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module